Lupin shares in focus after FDA approval for generic HIV tablets
Shares of Lupin will remain in focus on Thursday after the drugmaker received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for HIV tablets emtricitabine and tenofovir alafenamide tablets, 200 mg/25 mg. “We wish to confirm that the Company has received approval from the United States Food…
READ MORE